Related references
Note: Only part of the references are listed.Electrochemical and optical detection and machine learning applied to images of genosensors for diagnosis of prostate cancer with the biomarker PCA3
Valquiria C. Rodrigues et al.
TALANTA (2021)
Electrochemical aptasensors for cancer diagnosis in biological fluids - A review
Ana Diaz-Fernandez et al.
ANALYTICA CHIMICA ACTA (2020)
Electrochemical Aptasensor for Detection of Dopamine
Hisham Abu-Ali et al.
CHEMOSENSORS (2020)
Recent Advances in Aptamer Discovery and Applications
Yang Zhang et al.
MOLECULES (2019)
Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors
Juliana Coatrini Soares et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Morphology-dependent MnO2/nitrogen-doped graphene nanocomposites for simultaneous detection of trace dopamine and uric acid
Qing Li et al.
Materials Science & Engineering C-Materials for Biological Applications (2019)
Development of Novel and Highly Specific ssDNA-Aptamer-Based Electrochemical Biosensor for Rapid Detection of Mercury (II) and Lead (II) Ions in Water
Hisham Abu-Ali et al.
CHEMOSENSORS (2019)
Review-Recent Developments on Graphene-Based Electrochemical Sensors toward Nitrite
Guangli Li et al.
JOURNAL OF THE ELECTROCHEMICAL SOCIETY (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
New biomarkers for diagnosis and prognosis of localized prostate cancer
Dimitry A. Chistiakov et al.
SEMINARS IN CANCER BIOLOGY (2018)
Detection of ochratoxin A in aptamer assay using total internal reflection ellipsometry
Ali Al Rubaye et al.
SENSORS AND ACTUATORS B-CHEMICAL (2018)
Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review
Carmen Bax et al.
CANCERS (2018)
Graphene Oxide-Upconversion Nanoparticle Based Optical Sensors for Targeted Detection of mRNA Biomarkers Present in Alzheimer's Disease and Prostate Cancer
Patrick Vilela et al.
ACS SENSORS (2017)
Carbon Nanomaterial Based Biosensors for Non-Invasive Detection of Cancer and Disease Biomarkers for Clinical Diagnosis
Tibor Pasinszki et al.
SENSORS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Electrochemical aptamer-based biosensors as potential tools for clinical diagnostics
Marta Jarczewska et al.
ANALYTICAL METHODS (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Electrochemical Biosensors for Cancer Biomarkers Detection: Recent Advances and Challenges
Seda Nur Topkaya et al.
ELECTROANALYSIS (2016)
Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
Xavier Filella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer
Carlotta Buzzoni et al.
EUROPEAN UROLOGY (2015)
The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation
Amanda Nicholson et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
Prostate-specific RNA aptamer: promising nucleic acid antibody-like cancer detection
Karina Marangoni et al.
SCIENTIFIC REPORTS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer
Muhammad Daniyal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Screening for Prostate Cancer With the Prostate-Specific Antigen Test A Review of Current Evidence
Julia H. Hayes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Noncoding RNAs as Novel Biomarkers in Prostate Cancer
C. G. H. Ronnau et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Long and Winding Road to FDA Approval of a Novel Prostate Cancer Test: Our Story
Harry Rittenhouse et al.
CLINICAL CHEMISTRY (2013)
Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients
Roland R. Goode et al.
PROSTATE (2013)
Aptamers: A Promising Tool for Ochratoxin A Detection in Food Analysis
Amina Rhouati et al.
TOXINS (2013)
International Variation in Prostate Cancer Incidence and Mortality Rates
Melissa M. Center et al.
EUROPEAN UROLOGY (2012)
Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer
A. K. Wu et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2012)
A Review on the Clinical Utility of PSA Cancer Prostate
Mohan Adhyam et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2012)
Detection of low molecular weight toxins using an optical phase method of ellipsometry
A. Nabok et al.
SENSORS AND ACTUATORS B-CHEMICAL (2011)
Selection and analytical applications of aptamers binding microbial pathogens
Camille L. A. Hamula et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2011)
PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols
Michael A. Liss et al.
WORLD JOURNAL OF UROLOGY (2011)
Label-free biomarker detection from whole blood
Eric Stern et al.
NATURE NANOTECHNOLOGY (2010)
The Novel Prostate Cancer Antigen 3 (PCA3) Biomarker
Andreas Bourdoumis et al.
INTERNATIONAL BRAZ J UROL (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
A Duplex Quantitative Polymerase Chain Reaction Assay Based on Quantification of α-Methylacyl-CoA Racemase Transcripts and Prostate Cancer Antigen 3 in Urine Sediments Improved Diagnostic Accuracy for Prostate Cancer
Bin Ouyang et al.
JOURNAL OF UROLOGY (2009)
Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)
Stacy Loeb et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Alexander Haese et al.
EUROPEAN UROLOGY (2008)
Use of multiple biomarkers for a molecular diagnosis of prostate cancer
KA Landers et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Determination of affinities and antigenic epitopes of bovine cardiac troponin I (cTnI) with monoclonal antibodies by surface plasmon resonance biosensor
X Liu et al.
ANALYTICAL BIOCHEMISTRY (2003)
Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma
K Mistry et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE (2003)
New targets for therapy in prostate cancer: Differential display code 3 (DD3(PCA3)) a highly prostate cancer-specific gene
JA Schalken et al.
UROLOGY (2003)
Share Paper
